Researchers say our dreams are reflecting fears and anxiety associated with the COVID-19 pandemic. Read More
Melatonin produced in the lungs acts as a barrier defense against SARS-CoV-2, the virus that causes COVID-19, by blocking the expression of genes that encode proteins in cells acting as viral entry points. Read More
Researchers used epigenetic modulators to reduce the damage done by stress to neuroplasticity. Findings reveal acute intervention in epigenetic mechanisms produced antidepressant effects more rapidly than conventional medications. Read More
Focusing on genes associated with psychiatric and neurological disorders, and drugs approved for use in other diseases, a new AI system can increase the effectiveness of drug repurposing. Read More
Lack of oxygen to the fetus during pregnancy as a result of pre-eclampsia may increase the risk for schizophrenia, a new study reports. Read More
Cannabidiol (CBD) can inhibit aggressiveness associated with social isolation, a new mouse model study reveals. Read More
Using a green filter help to increase reading speed for children with dyslexia, researchers report. Read More
A study using rat models of depression reveals a single dose of the cannabis extract CBD can help to reduce symptoms of depression for up to one week. Researchers say cannabidiol appears to activate mechanisms that help repair neural circuitry in the prefrontal cortex and hippocampus, which get damaged as a result of depression. Read More
Brain dysfunction noted in schizophrenia patients may be a result of impaired expression of a protein complex associated with protein synthesis, researchers report. Read More
